(Date:12/16/2009)... -- Smart Balance, Inc. (Nasdaq: SMBL ) announced ... two-year stock repurchase program of up to $25 million, ... the confidence we have in the prospects of our ... for all of our shareholders, while at the same ... Smart Balance, Inc. Chairman and Chief Executive Officer. ,, ...
(Date:12/16/2009)... minorities might not gain full benefit from breakthroughs, experts ... embryonic stem cell lines currently used for research come ... , That could mean that non-whites will benefit less ... down the line, experts say. , Blacks could be ... used stem cell lines studied showed any traces of ...
(Date:12/16/2009)... Dec. 16 For wounded U.S. ... Center in Washington, D.C., the holidays can be a ... to travel home rely more than ever on the ... This week, calling home just got easier for Walter ... calling cards, which will provide hundreds of minutes of ...
(Date:12/16/2009)... deadly, attack is long-term goal, researchers say , , ... a tool to predict whether a patient will suffer ... stroke. , "This is an important new tool because ... stroke soon after a first stroke are more likely ... of Massachusetts General Hospital and Harvard Medical School, said ...
(Date:12/16/2009)... an advance that could help ease health and environmental ... development of technology for changing the behavior of nanoparticles ... into the environment. Their study was published in ACS, ... Jarvie from the UK Centre for Ecology and Hydrology ... the production of nanoparticles particles less than 1/1000th ...
Breaking Medicine News(10 mins):Health News:Smart Balance Authorizes Stock Repurchase Program 2Health News:Most Stem Cells Used in Research Come From Whites 2Health News:Verizon Wireless Donates $10,000 in Long-Distance Calling Cards to Soldiers at Walter Reed Hospital 2Health News:New Stroke Tool May Predict Early Recurrence 2Health News:Behavior modification could ease concerns about nanoparticles 2... everyday and more than a third hardly ever eat ... ,Researchers with Deakin’s Centre for Physical Activity and ... aged 12—15 years to evaluate their food intake patterns. ... of adolescents fell short of the recommendations outlined in ...
... global biotechnology company, has released// promising early results of a ... could significantly reduce the treatment time, it has been shown. ... trial on telaprevir were announced at Barcelona on Saturday at ... Study of the Liver (EASL). ,This drug ...
... questionnaire prepared by researchers has found that nine out of ... add more to that it was found that at least ... type of bullying in the past year. ... such as threatening physical harm, and indirect, such as excluding ...
... University of Toronto is revealing biochemical processes responsible// for ... pave the way for pharmaceutical applications. ... that play an important role in human health and ... system), scans cells to detect proteins that interact with ...
... scientists at Bonn University have created a software system that ... //With the aid of the software, the visual prosthesis "learns" ... be interpreted by the brain. ,Nearly two dozens of ... implanted with a visual prosthesis. For this purpose, clinicians open ...
... “night owl” complains more symptoms related to insomnia, ... their nocturnal sleeplessness, according to a study. ... and colleagues at Stanford University, consisted of 312 ... evening chronotypes based upon scores on the Morningness-Eveningness ...
Other Medicine News:Health News:Poor Diet Puts Teenagers' Health at Risk 2Health News:New Hepatitis C Drug Shows Promise 2Health News:Harassment in School Affects Majority of Elementary Students 2Health News:Harassment in School Affects Majority of Elementary Students 3Health News:New Technology Reveals Proteins Responsible for Diseases 2Health News:Software System to Improve the Function of Retinal Implants 2Health News:Software System to Improve the Function of Retinal Implants 3Health News:Insomnia-related Symptoms High Among ‘Night Owls 2(Date:12/16/2009)... (OTC Bulletin Board: HEWA) an online U.S. mail-order pharmacy, ... per annum short term debt financing. The structure ... $500,000, with accrued interest and principal repayable in one ... and principal repayable in one year from its funding, ... any calendar month prior to December 15, 2010. ...
(Date:12/16/2009)... NEW YORK, December 16 ... the publication of GFT505 (80 mg/day),data ... 50 internationally,recognized expert scientists and clinicians ... the continuing role of generic lipid-modifying,treatments, ... which is commonly observed in patients ...
(Date:12/16/2009)... CareCentrix, Inc ., the nation,s ... announced today that it has been awarded Health ... care accrediting organization that establishes quality standards for ... only appropriately trained, qualified clinical personnel conduct and ... and timely appeals process is in place, and ...
Breaking Medicine Technology:HealthWarehouse.com, Inc. Secures $1 Million in Debt Financing 2International, Well-Known Scientific Experts Say That New GFT505 Data Unlikely to Have the Potential to Affect the Established Role of Generic Fenofibrate and Bezafibrate in Managing Atherogenic Dyslipidemia 2International, Well-Known Scientific Experts Say That New GFT505 Data Unlikely to Have the Potential to Affect the Established Role of Generic Fenofibrate and Bezafibrate in Managing Atherogenic Dyslipidemia 3CareCentrix Receives URAC Health Utilization Management Accreditation 2New drugs faster from natural compounds 3A A UC San Diego breakthrough 13003 1New drugs faster from natural compounds 3A A UC San Diego breakthrough 13003 2New drugs faster from natural compounds 3A A UC San Diego breakthrough 13003 3New drugs faster from natural compounds 3A A UC San Diego breakthrough 13003 4Scientists discover repulsive side to light force 13000 1Scientists discover repulsive side to light force 13000 2State Budget Will Hurt Care in Skilled Nursing Facilities 51559 1State Budget Will Hurt Care in Skilled Nursing Facilities 51559 2... Gene therapy to replace the,faulty CLN2 gene, which causes ... was able to slow significantly the rate of neurologic,decline ... ahead of,print in the May 2008 issue (Vol. 19 ... by Mary Ann Liebert, Inc. The paper is,available free ...
... V in SPIRIT III Trial Experience Better, Long-Term Clinical Outcomes, Lower ... ... with TAXUS, BARCELONA, Spain, May 13 Long-term data,presented for ... trial studying the XIENCE(TM) V Everolimus Eluting Coronary Stent,System, demonstrated that ...
Other Medicine Technology:Gene Therapy Slows Progression of Fatal Neurodegenerative Disease in Children 2XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 2XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 3XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 4XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 5... ToRCH Plus IgM Controls identify ... in your ToRCH IgM immunoassay ... test results. Liquichek ToRCH Plus ... complement to Liquichek ToRCH Plus ...
... Liquichek ToRCH Plus Control is ... to monitor the performance of ... instruments and assays. A weak ... allow you to monitor the ...
Liquichek Unassayed Chemistry Control (Human) is a comprehensive, stable, liquid product designed to monitor general and special chemistry tests....
... Lyphochek Unassayed Chemistry Control (Human) provides ... stability for enzymes and CO2. It ... compatible with most major instruments and ... 10 mL fill sizes (10 mL ...
Medicine Products:Biology NavigationMedical Navigation